RecruitingNCT05400590

Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

Studying Developmental defect of the eye

Last synced from ClinicalTrials.gov May 9, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Principal Investigator: Eric GABISON
Hôpital Fondation A. de Rothschild
Intervention: Peripheral venous blood sample(procedure)
Enrollment: 24 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2026

Study locations (1)

Hôpital Fondation A. de Rothschild, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05400590 on ClinicalTrials.gov

Other trials for Developmental defect of the eye

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE3NCT06106828
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
Hoffmann-La Roche

See all trials for Developmental defect of the eye →

← Back to all trials